Trials / Recruiting
RecruitingNCT07117981
Describe the Progression of Inflammatory Orbitopathy and the Biological Progression of Patients Receiving Second-line Treatment
Treatment of Graves' Orbitopathy in Patients Failing Corticosteroid Therapy: Multicenter National Retrospective Study- Basedow
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Describe the progression of inflammatory orbitopathy and the biological progression of patients receiving second-line treatment (immunosuppressants, radiotherapy, or biotherapy).
Conditions
Timeline
- Start date
- 2024-11-01
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2025-08-12
- Last updated
- 2025-08-15
Locations
9 sites across 1 country: France
Source: ClinicalTrials.gov record NCT07117981. Inclusion in this directory is not an endorsement.